The present invention relates to symmetric tetraalkynylated anthracenes which exhibit photophysical properties. More particularly, the present invention relates to symmetric tetraethynylated anthracene compounds of Formula III and a novel process for synthesizing symmetric tetraethynylated anthracene compounds of Formula III.
The immense development in the field of organic fluorescence especially organic light-emitting diodes (OLEDs), organic field-effect transistors (OFETs), solar cells, and sensors, and have gained tremendous attention owing to their outstanding performance efficiency and an economic solution to other light displays.
Polyalkylynation of polyaromatic hydrocarbons (PAHs) having aromatic nucleus like benzene, naphthalene, anthracene, pyrene, perylenes and chrysene have found application in the field organic fluorescence as they offer dynamic scope in tuning the photo physical properties of these compounds. Polyalkylynation of the PAHs not only improves the π-conjugation but also significantly improves their thermal stability paving ways for fabrication in optoelectronic devices with tunable properties.
Anthracenes have been known for longer time as blue time emitting compounds and possess high fluorescence and quantum yield because of its highly conjugated and rigid structure.
Steady state and time resolved fluorescence emission properties of symmetrical dialkoxyanthracenes (especially substituted on the side rings) have been reported by T. brotin et al (Photochemistry and Photobiology Vol. 55, No. 3, pp. 349-358. 1992).
The US20050233165 disclosed an anthracene derivative represented by the following general Formula I which enables an organic electroluminescence device to exhibit a great efficiency of light emission and uniform light emission even at high temperatures.
Ar represents a group represented by the following general Formula II:
Another US2008475940 disclosed an anthracene derivative with Formula I which are used in Light emitting device.
Park et al; (J.-H. Park et al./Organic Electronics 11 (2010) 820-830); discloses preparation and characterization of single crystals and thin films composed of three new small molecules based on soluble triisopropylsilylethynyl (TIPS)-substituted anthracene (TIPSAnt) for use in organic thin-film transistors (TFTs). The disclosed molecules are TIPSAnt derivatives containing thiophene (TIPSAntT), benzothiophene (TIPSAntBeT), or phenyl thiophene (TIPSAntPT) end cappers. The synthesis of the above compounds was carried out using tetrakis(triphenyl phosphine)palladium(0), sodium carbonate and phase transfer catalyst Aliquat-336 in THF as solvent and the reaction was carried out for 3 days.
Choi et al discloses synthesis unsymmetrical 2, 6, 9, 10-tetraalkynylatedanthracene molecules by two-step. A) synthesis of the symmetrical dial-kynylarylanthracene-9, 10-dione starting from 2, 6-dibromoanthracene-9, 10-dione via a Sonogashira coupling. B) Introduction of second pair of alkynyl groups to 2, 6-dialkynylaryl-9, 10-dione by the treatment of appropriate alkynes in the presence of SnCl2 and HCl leading to 2, 6, 9, 10-tetraalkynylatedanthracene.
PAHs with anthracene core that has three rigid fused aromatic ring containing 14π-electron that typically has a bandgap of 3.9 eV and gives high fluorescence quantum yield owing to optimal vibronic energy level. PAHs with anthracene core offer wider scope for optimization and derivatization which would be helpful in tuning Photophysical Properties of these Anthracenes. The design and synthesis of tetraalkynylated anthracene derivate with desired properties and convenient and robust Synthetic approach still remains unexplored. The current state of art focus mainly on non-symmetric anthracene derivate, and further the process involved in synthesis of tetraalkynalated anthracenes are tedious and require longer duration for completion.
None of the prior arts either disclose symmetric tetraalkynalated anthracenes nor any synthetic route for development of such compounds. In light of the above, there exists a need to explore new anthracene derivatives and substantially the new approaches for synthesizing these derivatives. The present invention is an endeavor in this direction.
The main object of the present invention is to provide a novel process for synthesis of symmetric tetraalkynylated anthracenes with Formula III by tetrafold sonogashira coupling.
Another object of the present invention is to provide a single step one pot route for synthesis of the symmetric tetraalkynylated anthracenes.
Yet another object of the present invention is to provide new symmetric tetraethynylated anthracenes which show positive solvatochrism and halochromism.
Yet another object of the present invention is to explore the photophysical properties of these symmetric tetraethynylated anthracenes.
Yet another object of the present invention is to provide crystallographically characterized tetraalkynylated anthracenes.
Still another object of the present invention is to provide anthracene derivatives which find applications in sensors and optoelectronic devices.
This summary is only intended to provide an introduction of the invention and does not determine the scope of the invention. This summary only introduces the aspects of the invention in a simpler form.
The present invention relates to symmetric tetraalkylynated anthracenes and more particularly to tetraethynylated anthracenes and a novel process for synthesis of symmetric tetraethynylated anthracenes of Formula III;
Where R is hydrogen, alkyl, halo, aryl, substituted aryl, hetroaryl;
In an embodiment, the present invention provides a direct single-step one-pot route to synthesis of symmetric tetraethynylated anthracene compounds with Formula III.
In another embodiment, the present invention provides a general scheme for synthesis of compounds with Formula III;
In another embodiment, the present invention provides compounds general Formula III which show positive solvatochrism and halochromism.
The above objects and advantages of the present invention will become apparent from the hereinafter set forth brief description of the drawings, detailed description of the invention, and claims appended herewith.
An understanding of the novel process of the present invention may be obtained by reference to the following drawings:
The present invention now will be described hereinafter with reference to the detailed description, in which some, but not all embodiments of the invention are indicated. Indeed, the invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements. Like numbers refer to like elements throughout. The present invention is described fully herein with non-limiting embodiments and exemplary experimentation.
The present invention provides a single step one pot route for synthesis of compound of Formula III via tetrafold sonogashira coupling.
where R is hydrogen, alkyl, halo, aryl, substituted aryl, hetroaryl;
In an embodiment of the present invention is provided a tetra fold sonogashira coupling process for synthesis of compound of Formula III
generally comprising the step of:
In an embodiment of the present invention, Scheme-2 utilizes a combination of palladium catalyst, Bis(acetonitrile)dichloropalladium(II) (Pd(CH3CN)2Cl2) and ligand cataCXium®A in a ratio of 1:2.
In a preferred embodiment of the invention, the solvent used in the Scheme-2 is selected from tetrahydrofuran (THF), toluene, N-alkylpyrrolidones, dimethylformamide (DMF), Dioxane or mixture thereof.
In a preferred embodiment of the invention base is selected from trimethylamine, potassium carbonate, potassium bicarbonate, sodium bicarbonate, cesium carbonate, potassium hydroxide, piperidine. Sodium tert-butoxide, potassium tert-butoxide.
In a preferred embodiment of the invention the base and solvent are present in a ratio of 1:1 and the compound of Formula I and compound of Formula II are present in a ratio of 1:6.
In an embodiment of the invention are provided compounds with general Formula III prepared by the scheme III;
Referring to
Referring to
Referring to
Referring to
Referring to
The gas sensing chamber was purged with nitrogen before being vacuumed three times to avoid cross-contamination. The sensors' baseline readings were taken in a nitrogen ambient, at less than 1% humidity and close to atmospheric pressure. Sweeping voltage from 0 to 5 V was used to analyse the I-V characteristic of sensing devices. The device shows a ohmic characteristic. A series of experiments were carried out to evaluate the response of the devices by varying the concentration of hydrogen gas from 100 to 9000 ppm. The electrical properties confirm an increase in current with increasing hydrogen concentration. The interaction with H2 gas reduces the device's resistance. Because H2 is a reducing gas, interacting with it raises the concentration of surface electrons on n type semiconductors. The following equation was used to determine the response of the gas sensors.
where Rg is the average electrical resistance obtained by sweeping the voltage from 0 to 5V toward varying H2 concentrations, and Ro is the average electrical resistance of the sensors in the nitrogen atmosphere.
Referring to
Referring to
where slope denotes the average electrical resistance for the various analyte gas concentrations and σ is the standard deviation of the base reading.
Referring to
Referring to
Referring to Table 2 of the present invention is illustrated, the photophysical properties of tetraethynylated anthracenes synthesized via tetra-fold Sonogashira coupling. aThe absorption (10−5 M) as well as emission (10−6 M) spectra recorded in CHCl3. b Log (ε) was calculated from the plot of absorbance vs concentration. cEmission spectra were recorded on glass on which a thin film was prepared by drop-cast method. dEmission spectra were recorded in powder form of the compounds. eQuantum yield were calculated with respect to quinine sulfate in 0.1 M H2SO4 as standard (φ=54%). fThe average lifetime of the compounds calculated by using the equationwhere τav=average lifetime in excited state of the luminescence compound, B=pre-exponential factor, τi=decay lifetime of photoluminescence in excited state for the ith component. gThe band-gaps were calculated from the Tauc plot. determined from cyclic voltammetry. iELUMO from cyclic voltammetry.
The quantum yield is the ratio between the emitted number of photons and the absorbed number of photons by the fluorophores. Relative fluorescence quantum yield was calculated by the following equation (1),
Where ΦF and ΦR are relative quantum yields of analyte and reference respectively; I, IR are the area of emission of the analyte and reference; A, AR are the maximum absorbance of analyte and reference; η, ηR are the refractive index of analyte and reference solutions, respectively.
General Procedure for Synthesis of Compounds with Formula III:
A two-neck round bottom flask was taken, evacuated and charged with argon three times. anhydrous triethylamine (7 mL) and anhydrous THF (7 mL) were added into the round bottom flask and the solvent was degassed by freeze-pump-thaw process. This was followed by addition of 2, 6, 9, 10-tetrabromoanthracene (0.404 mmol), Pd(CH3CN)2Cl2 (0.0404 mmol), CataCXium® A (0.0810 mmol), CuI (0.0810 mmol), and alkyl/aryl acetylene (2.43 mmol) which were then stirred under reflux condition overnight. After the completion of the reaction, the reaction mixture was passed through celite by using DCM (200 mL×3) as eluent and filtrate was evaporated under reduced pressure. NMR yield of crude product was determined by 1H NMR 1, 4-dioxane as external standard. The crude product was purified by column chromatography (eluent: Hexane and DCM).
The compound was prepared following the general procedure for synthesis of compound of Formula III. The crude product was purified by column chromatography (eluent: 35% DCM in hexane). The product obtained was an orange solid with yield 58%. 1H NMR (400 MHZ, CDCl3) δ 8.79 (d, J=0.8 Hz, 2H), 8.60 (d, J=8.9 Hz, 2H), 7.69 (dd, J=6.2, 4.9 Hz, 5H), 7.66 (d, J=1.5 Hz, 1H), 7.53 (d, J=8.0 Hz, 4H), 7.28 (d, J=7.9 Hz, 4H), 7.20 (d, J=7.9 Hz, 4H). 2.45 (s, 6H), 2.40 (s, 6H). 13C{1H} NMR (151 MHz, CDCl3) δ 139.32, 138.88, 132.01, 131.87, 131.85, 131.67, 130.76, 129.51, 129.34, 127.63, 122.11, 120.26, 120.19, 118.45, 103.35, 91.88, 89.67, 85.52, 21.83, 21.75. MALDI-TOF calculated exact mass for C50H34 (M+): 634.26, found: 634.91.
The compound was prepared following the general procedure for synthesis of compound of Formula III. The crude product was purified by column chromatography (eluent: 40% DCM in hexane) The product obtained was a red solid with yield 61%. 1H NMR (400 MHZ, CDCl3) δ 9.10 (s, 2H), 8.74 (d, J=8.9 Hz, 2H), 7.82-7.69 (m, 4H), 7.60 (dd, J=7.5, 1.6 Hz, 2H), 7.38 (ddd, J=15.6, 8.7, 1.6 Hz, 4H), 7.01 (ddd, J=26.0, 17.0, 8.0 Hz, 8H), 4.12 (s, 6H), 3.97 (s, 6H). 13C{1H} NMR (151 MHz, CDCl3) δ 160.73, 160.20, 133.81, 133.01, 132.19, 131.50, 131.39, 130.37, 130.11, 129.58, 127.67, 122.16, 120.71, 118.79, 112.85, 112.61, 110.87, 110.75, 99.87, 94.67, 91.01, 87.65, 56.00, 55.98. MALDI-TOF calculated exact mass for C50H34O4 (M+): 698.24, found: 698.65.
The compound was prepared following the general procedure for synthesis of compound of Formula III. The crude product was purified by column chromatography (eluent: 90% DCM in hexane). The product obtained was a maroon solid with yield 88%. 1H NMR (400 MHZ, CDCl3) δ 8.87 (s, 2H), 8.67 (d, J=8.9 Hz, 2H), 7.94 (s, 8H), 7.84 (dd, J=14.4, 7.7 Hz, 12H), 7.77 (t, J=9.2 Hz, 6H), 7.63 (q, J=7.2 Hz, 4H), 7.53 (q, J=7.4 Hz, 8H). 13C{1H} NMR (151 MHz, CDCl3) δ 196.06, 195.99, 137.71, 137.50, 137.45, 137.34, 132.90, 132.80, 132.21, 132.04, 131.83, 131.81, 131.19, 130.50, 130.33, 130.19, 130.15, 129.88, 128.62, 128.57, 127.78, 127.30, 127.15, 122.10, 118.67, 102.82, 92.87, 91.44, 88.66. MALDI-TOF calculated exact mass for C74H4204 (M+): 994.30, found: 994.86.
The compound was prepared following the general procedure for synthesis of compound of Formula III. The crude product was purified by column chromatography (eluent: 60% DCM in hexane). The product obtained was a brown solid with yield 64%. 1H NMR (400 MHZ, CDCl3) δ 8.78 (s, 2H), 8.60 (d, J=8.8 Hz, 2H), 7.68 (d, J=8.7 Hz, 4H), 7.64 (d, J=8.1 Hz, 2H), 7.52 (d, J=8.7 Hz, 4H), 6.78 (d, J=8.9 Hz, 4H), 6.70 (d, J=8.8 Hz, 4H), 3.06 (s, 12H), 3.02 (s, 12H). 13C{1H} NMR (151 MHZ, CDCl3) δ 150.55, 150.34, 133.13, 133.11, 131.85, 131.34, 130.25, 129.25, 127.59, 122.19, 118.19, 112.12, 112.01, 110.37, 110.25, 104.33, 92.70, 88.78, 84.84, 40.42, 40.39. MALDI-TOF calculated exact mass for C54H46N4 (M+): 750.37, found: 750.90.
The compound was prepared following the general procedure for synthesis of compound of Formula III. The product obtained was a maroon solid with yield 31%. 1H NMR (400 MHZ, CDCl3) δ 8.76 (d, J=0.8 Hz, 2H), 8.58 (d, J=8.9 Hz, 2H), 7.67-7.61 (m, 6H), 7.46 (d, J=8.7 Hz, 4H), 7.29 (dt, J=9.7, 4.9 Hz, 15H), 7.15 (dd, J=14.7, 8.0 Hz, 18H), 7.07 (ddd, J=21.2, 9.4, 5.3 Hz, 15H). 13C{1H} NMR (151 MHZ, CDCl3) δ 148.61, 148.27, 147.30, 147.23, 132.91, 132.88, 131.96, 131.56, 130.58, 129.62, 129.56, 129.42, 127.61, 125.31, 125.21, 123.91, 123.77, 122.35, 122.11, 118.28, 116.00, 115.97, 103.60, 92.03, 89.70, 85.64. MALDI-TOF calculated exact mass for C94H62N4 (M+): 1247.50, found: 1247.97.
The compound was prepared following the general procedure for synthesis of compound of Formula III. The crude product was purified by column chromatography (eluent: hexane). The product obtained was a yellow solid with yield 83%. 1H NMR (600 MHz, CDCl3) δ 8.66 (s, 2H), 8.44 (d, J=8.9 Hz, 2H), 7.57 (dd, J=8.9, 1.3 Hz, 2H), 0.43 (s, 18H), 0.31 (s, 18H). 13C{1H} NMR (151 MHz, CDCl3) δ 132.16, 131.82, 131.77, 129.55, 127.48, 121.92, 118.47, 109.46, 105.59, 100.92, 96.83, 0.22, 0.10. MALDI-TOF calculated exact mass for C34H42Si4 (M+): 562.23, found: 562.62.
The compound was prepared following the general procedure for synthesis of compound of Formula III. The crude product was purified by column chromatography (eluent: 40% DCM in hexane). The product obtained was a yellow powder with yield 59%. 1H NMR (600 MHZ, CDCl3) δ 8.73 (s, 2H), 8.55 (d, J=8.9 Hz, 2H), 7.68 (d, J=8.9 Hz, 2H), 7.56 (d, J=3.5 Hz, 2H), 7.45 (d, J=5.1 Hz, 2H), 7.40 (d, J=3.4 Hz, 2H), 7.36 (d, J=5.1 Hz, 2H), 7.17-7.13 (m, 2H), 7.08-7.05 (m, 2H). 13C{1H} NMR (151 MHz, CDCl3) δ 132.94, 132.65, 131.88, 131.65, 130.61, 129.43, 128.53, 127.98, 127.67, 127.64 127.40, 123.27, 123.09, 121.93 118.33, 96.50, 93.82, 89.80, 85.26. MALDI-TOF calculated exact mass for C38H18S4 (M+): 602.02, found: 602.36.
The compound was prepared following the general procedure for synthesis of compound of Formula III. The crude product was purified by column chromatography (eluent: 40% DCM in hexane). The product obtained was a brown powder with yield 20%. 1H NMR (400 MHZ, CDCl3) δ 8.78 (s, 2H), 8.60 (d, J=8.9 Hz, 2H), 7.81 (dd, J=2.7, 1.3 Hz, 2H), 7.69 (d, J=1.6 Hz, 1H), 7.66 (d, J=1.5 Hz, 1H), 7.65-7.63 (m, 1H), 7.46-7.44 (m, 4H), 7.35 (dd, J=5.0, 3.0 Hz, 2H), 7.30 (dd, J=5.1, 0.9 Hz, 3H). 13C{1H} NMR (151 MHz, CDCl3) δ 132.00, 131.70, 130.74, 130.16, 130.08, 129.65, 129.50, 129.39, 127.65, 126.00, 125.71, 122.25, 122.21, 121.96, 118.37, 98.16, 89.64, 86.90, 85.47. MALDI-TOF calculated exact mass for C46H26 (M+): MALDI-TOF calculated exact mass for C38H18S4 (M+): 602.02, found: 602.41
Referring to Table 1 of the present invention, there is illustrated the yields and physical appearance of the compounds synthesized via tetra-fold Sonogashira coupling.
Therefore, the present invention provides a robust, efficient and a single step one pot process for synthesis of symmetric tetraethynylated compounds which show exciting photophysical properties where these symmetric tetraethynylated anthracenes exhibit solvatochromism and halochromism. The former also exhibits a low band-gap of 1.79 eV in the solid-state. The present invention synthesizes the symmetric tetraethynylated compounds in good to excellent yield.
Many modifications and other embodiments of the invention set forth herein will readily occur to one skilled in the art to which the invention pertain having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the invention is not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.
Number | Date | Country | Kind |
---|---|---|---|
202131035020 | Aug 2021 | IN | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2022/057185 | 8/3/2022 | WO |